Sign in
AL

Astera Labs, Inc. (ALAB)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 2024 delivered record revenue of $141.1M, up 25% q/q and 179% y/y; non-GAAP EPS was $0.37, with CFO noting EPS would have been $0.30 absent a discrete tax benefit, implying an operational beat versus internal expectations .
  • Gross margin compressed as mix shifted toward hardware modules (Aries/Taurus SCMs): non-GAAP GM fell to 74.1% from 77.8% in Q3; CFO reiterated a longer-term GM model around 70% depending on mix .
  • Initial Q1 2025 guidance calls for revenue of $151–$155M (+7–10% q/q) and non-GAAP EPS of $0.28–$0.29, with continued Aries/Taurus growth and increasing Scorpio contributions; Leo (CXL) expected to ramp in 2H25 .
  • Strategic catalyst: Scorpio Smart Fabric switches (P-Series head-node connectivity; X-Series back-end clustering) are expected to comprise at least 10% of 2025 revenue, with management stating Scorpio can become the largest product line over time due to its TAM and ASP profile .

What Went Well and What Went Wrong

What Went Well

  • Sixth consecutive quarterly revenue record: $141.1M (+25% q/q; +179% y/y), driven by strong demand for Aries PCIe retimers and Taurus Ethernet SCMs across AI scale-up and scale-out deployments .
  • Operating leverage on a non-GAAP basis: Q4 non-GAAP operating margin expanded to 34.3% (from 32.4% in Q3) as revenue outpaced opex growth; CFO highlighted the discrete tax benefit and interest income tailwind .
  • Strategic product momentum: preproduction shipments for Leo (CXL) and Scorpio switches, with first preproduction X-Series orders and P-Series expected to contribute in 2H25; CEO: “We expect 2025 to be a breakout year…driven by revenue from all four of our product families” .

What Went Wrong

  • Margins compressed: non-GAAP gross margin fell to 74.1% (vs 77.8% in Q3), reflecting higher mix of hardware modules (Aries/Taurus SCMs); CFO expects near-term GM ~74% and longer-term ~70% depending on mix .
  • Opex elevated: GAAP opex rose to $104.3M (R&D $56.5M, S&M $22.8M, G&A $25.0M) amid aggressive R&D scaling and a small acquisition; Q1 2025 non-GAAP opex guided higher at $66–$67M .
  • Guidance comparisons show mixed dynamics: Q4 non-GAAP gross margin came in below the prior 75% guide, though revenue and EPS both exceeded guidance (EPS benefited from tax accounting change) .

Financial Results

MetricQ4 2023Q3 2024Q4 2024
Revenue ($USD Millions)$50.514 $113.086 $141.096
Gross Margin % (GAAP)77.3% 77.7% 74.0%
Operating Margin % (GAAP)17.9% (7.9)% 0.1%
Net Income ($USD Millions, GAAP)$14.325 ($7.593) $24.713
Diluted EPS (GAAP)— ($0.05) $0.14
MetricQ4 2023Q3 2024Q4 2024
Gross Margin % (Non-GAAP)77.3% 77.8% 74.1%
Operating Margin % (Non-GAAP)24.4% 32.4% 34.3%
Net Income ($USD Millions, Non-GAAP)$17.624 $40.282 $66.492
Diluted EPS (Non-GAAP)$0.12 $0.23 $0.37
KPIQ4 2023Q3 2024Q4 2024
R&D Expense ($USD Millions, GAAP)$19.654 $50.659 $56.524
Sales & Marketing ($USD Millions, GAAP)$4.995 $23.248 $22.818
G&A ($USD Millions, GAAP)$5.356 $22.866 $24.962
Total Opex ($USD Millions, GAAP)$30.005 $96.773 $104.304
Interest Income ($USD Millions)$1.674 $10.912 $10.558
Cash & Marketable Securities ($USD Millions)$208.0 (Dec 31, 2023) $886.8 (Sep 30, 2024) $914.3 (Dec 31, 2024)

Segment breakdown: Not disclosed by product family (Aries, Taurus, Leo, Scorpio) on a quantitative basis; qualitative drivers were cited across releases and the call .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent Guidance / ActualChange
Revenue ($USD Millions)Q4 2024$126–$130 $141.1 (Actual) Beat
Gross Margin % (Non-GAAP)Q4 2024~75% 74.1% (Actual) Lower vs guide
Diluted EPS (Non-GAAP)Q4 2024$0.25–$0.26 $0.37 (Actual); ~$0.30 ex tax benefit Beat (benefited by tax)
Operating Expenses (Non-GAAP, $USD Millions)Q4 2024$54–$55 $56.2 (Actual, CFO) Slightly higher
Revenue ($USD Millions)Q1 2025N/A$151–$155 Initiated
Gross Margin % (Non-GAAP)Q1 2025N/A~74% Initiated
Operating Expenses (Non-GAAP, $USD Millions)Q1 2025N/A$66–$67 Initiated
Diluted EPS (Non-GAAP)Q1 2025N/A$0.28–$0.29 Initiated

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 2024)Previous Mentions (Q3 2024)Current Period (Q4 2024)Trend
AI platform mix (merchant GPU vs internal ASIC)Focus on Aries 6 sampling; general AI buildouts Ramping across both merchant GPUs and internal accelerators; diversified growth 1H25 led by internal accelerators; merchant GPU ramps in 2H25; Scorpio content adds in back half Increasing internal ASIC near-term; merchant GPU later 2025
Aries/Taurus product performanceAries 6 sampling; Taurus AEC SCMs announced Taurus 400G initial production ramp; Aries remains largest contributor Q4 upside driven notably by Taurus; continued Aries/Taurus strength into Q1 Broadening deployments; higher-speed transitions
Scorpio Smart Fabric switchesLaunch; preproduction shipping; design wins Scorpio expected >10% of 2025 revenue First X-Series preproduction orders; P-Series revenue contribution expected in 2H25; long-term largest product line potential Accelerating engagements; meaningful 2025 contribution
CXL (Leo) rampPreproduction volumes; ecosystem building Preproduction; use cases maturing Ramp expected in 2H25; initial high-memory bandwidth applications Crawl-to-walk; production starts 2H25
Margins/mixGuide to ~75% in Q4 on hardware mix Q3 non-GAAP GM 77.8% (better mix) Q4 non-GAAP GM 74.1%; Q1 ~74%; long-term ~70% depending on mix Down near term on modules; stable ~74% in 1H25
Supply chain/inventory——Inventory rebuilt to normalized levels after Q3 drawdown to support upside/sole-source programs Prepared for upside; sole-source position
UALink (industry standard)Joined Board; promoting member —Spec near end of Q1; earliest products ~2026; Astera to develop full portfolio Early leadership; standard maturation

Management Commentary

  • CEO: “We expect 2025 to be a breakout year as we enter a new phase of growth driven by revenue from all four of our product families…including our flagship Scorpio Fabric products for head-node PCIe connectivity and backend AI accelerator scale-up clustering.”
  • COO: “We are pleased to report that we have received the first preproduction orders for our Scorpio X-Series…P-Series is what we expect to start contributing meaningful revenue starting second half of this year.”
  • CFO: “Non-GAAP diluted EPS for the quarter was $0.37…excluding the impact of the Q4 tax benefit…non-GAAP EPS would have been $0.30…We expect Q1 revenues to increase to $151–$155 million.”

Q&A Highlights

  • Mix shift: 1H25 skewed to internal ASIC programs; 2H25 merchant GPU custom racks drive Scorpio content; attach rates and customization elongate ramp timing .
  • Margins: Hardware module mix (Aries/Taurus SCMs) drove Q4 GM down to 74.1%; near-term GM ~74%; long-term ~70% varies with silicon vs hardware mix .
  • Scorpio competitiveness: Purpose-built for AI with COSMOS software stack; first PCIe Gen6 switch; potential to become largest product line via higher ASPs and greenfield back-end TAM .
  • DeepSeek implications: Algorithmic improvements lower inference cost and increase adoption; hyperscalers have raised CapEx post announcements, reinforcing secular AI demand .
  • CXL/Leo: Initial deployments in high-memory bandwidth/HPC use cases starting 2H25; broader mainstream adoption expected in 2026–2027 .

Estimates Context

  • Wall Street consensus (S&P Global) data was not retrievable at this time due to system limits; therefore, estimate comparisons are not included. We benchmarked results against company guidance from Q3 and initial Q1 2025 guidance .

Key Takeaways for Investors

  • Revenue and EPS materially beat prior Q4 guidance; note that EPS benefited from a tax accounting change—normalized EPS of ~$0.30 still implies an operational beat and strong leverage .
  • Near-term margin headwind from hardware module mix should persist into Q1–Q2 (~74% non-GAAP GM), with mix improvement later in 2025 as silicon (Aries on-board, Leo, Scorpio) ramps; long-term GM model ~70% .
  • 2025 growth drivers: Scorpio switches (≥10% of 2025 revenue), continued Taurus 400G deployments (transition to 800G in late 2025/2026), Aries Gen5/Gen6 content, and Leo CXL ramp in 2H25 .
  • Cash and liquidity of ~$914M provides ample capacity to fund aggressive R&D and IP expansion; management targets 40% long-term operating margin driven by revenue scale rather than opex constraint .
  • Inventory rebuild to normalized levels positions ALAB to service upside demand in sole-source programs—supportive of sequential revenue growth into Q1 .
  • Strategic positioning in UALink and PCIe Gen6 places Astera at the forefront of next-gen AI fabrics, with back-end clustering TAM (X-Series) potentially the largest long-term opportunity .
  • Trading implications: Expect focus on sustained top-line growth, mix-driven margin trajectory, and evidence of Scorpio/Leo ramp milestones; any updates accelerating Scorpio contribution or confirming Leo production timing are likely stock catalysts .